<?xml version="1.0" encoding="UTF-8"?>
<p>The following phytoantivirals were investigated and compared to Chloroquine (CLQ), a potential COVID-19 prophylactic and therapeutic agent currently in clinical trials. The docking/binding studies results below show that the phytoantiviral flavonoids (Hesperetin, Myricetin, Linebacker, and Caflanone) could bind equally or more effectively than CLQ [
 <xref rid="B31-molecules-26-00607" ref-type="bibr">31</xref>].
</p>
